Scientists at the University of Utah (the U) have developed a new “lab-on-a-chip” device that uses artificial intelligence to rapidly predict cancer cell sensitivity to targeted therapies for children with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive and difficult-to-treat cancer.